Jun Hwa Hong
Daejeon Eul Ji Medical Center, Eul Ji University in Korea
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jun Hwa Hong as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:12 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06712615 · Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 DiabetesProGen. Co., Ltd. · active not recruiting · Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:12 UTC. The ranking covers the 200 most relevant of 133 PubMed records, and a shared surname and initials can bring in a namesake. All 133 on PubMed
- Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial.Lancet Oncol · 2013196 citationsRCR 5.1
- 156 citationsRCR 19.7
- 146 citationsRCR 5.2
- Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer.Gynecol Oncol · 2003145 citationsRCR 4.4
- 128 citationsRCR 4.8
- Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer.J Clin Oncol · 2000116 citationsRCR 3.1
- 97 citationsRCR 3.6
- Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients.Am J Transplant · 201391 citationsRCR 3.9
- 88 citationsRCR 2.5
- Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma.Ann Oncol · 201284 citationsRCR 2.1